Medical News

Surgery

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Petrelli F et al. – The clinical trials investigating new agents have to be designed for a specific subset of patients with BC. In the future, a gene array platform with greater sensitivity for distinguishing the various BC subtypes, as well as having the power to predict the molecular biology of the disease, will be an indispensible tool for treatment selection. Currently, treatment of TN BC is more empirical than evidence–based. The cornerstone of treatment is chemotherapy, but in the near future, novel target agents will emerge as possible partners.

Today in Breast...keeping you current

Delayed-Immediate Breast Reconstruction: Technical and Timing Considerations
Plastic and Reconstructive Surgery, 12/04/09

Use of the Acellular Dermal Matrix in Revisionary Aesthetic Breast Surgery
Aesthetic Surgery Journal, 12/03/09

Lymphangiogenic Characteristics of Triple Negativity in Node-Negative Breast Cancer
International Journal of Surgical Pathology, 12/03/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address